Related Experiment Video
Updated: Jun 28, 2026
07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
THC:YAG laser sclerostomy: the resident experience.
1Department of Ophthalmology, University of Texas Medical Branch, Galveston 77550.
Ophthalmic Surgery
|December 1, 1992
Summary
This study found that THC:YAG laser sclerostomies without anti-metabolites uniformly closed within six months. Recommendations include using anti-metabolites to improve outcomes and prevent complications.
Area of Science:
- Ophthalmology
- Surgical Innovation
Background:
- Glaucoma surgery aims to reduce intraocular pressure.
- Traditional glaucoma surgical techniques carry risks of bleb failure and complications.
- Thulium: YAG (THC:YAG) laser sclerostomy is a less invasive glaucoma surgical option.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of THC:YAG laser sclerostomy.
- To assess the closure rate of filtering blebs after THC:YAG laser sclerostomy without anti-metabolites.
- To identify potential complications and recommend protocol modifications.
Main Methods:
- Retrospective review of 14 consecutive cases undergoing THC:YAG laser sclerostomy.
- Absence of anti-metabolite use during the procedures.
- Follow-up assessment of filtering bleb patency and sclerostomy site status at 6 months.
Main Results:
- All 14 filtering blebs demonstrated uniform closure within 6 months.
- The sclerostomy sites were consistently closed by either iris tissue or fibrous scar tissue.
- No mention of intraocular inflammation or iris prolapse in the provided text, but these are mentioned as areas for future consideration.
Conclusions:
- THC:YAG laser sclerostomy performed without anti-metabolites leads to rapid bleb closure.
- The current protocol may require modification to include anti-metabolites.
- Future protocols should address the prevention and management of iris prolapse and intraocular inflammation to optimize surgical outcomes.
